Medical Advocates
Cryptococcosis
  Main Page

New/Noteworthy                 Transplant Studies
 Guidelines                          Systemic Studies
General Reports                 National Challenges 
Pediatric 
 Pregnant Women/Neonates 
Case Studies
Pathogenesis
Prevention
Diagnosis
Management
Drugs
 
OI Main Page Disease Main Page Main New/Newsworthy  Home Page 
Last Update:  February 01, 2012
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
     
January 2112
 
General Reports
 

        Journal Papers, Abstracts, and Commentaries

 
FULL-TEXT ARTICLE
Evidence that the Human Pathogenic Fungus Cryptococcus neoformans var. grubii May Have
Evolved in Africa.
Litvintseva AP, Carbone I, Rossouw J,  et al
PLoS One. 2011 May 11;6(5):e19688
Paper

An update on Cryptococcus among HIV-infected patients.
Warkentien T, Crum-Cianflone NF.
Int J STD AIDS. 2010 Oct;21(10):679-84
 Abstract

Cryptococcal interactions with the host immune system.
Voelz K, May RC.
Eukaryot Cell. 2010 Jun;9(6):835-46
 Abstract

Risk factors for mortality from primary cryptococcosis in patients with HIV.
Sajadi MM, Roddy KM, Chan-Tack KM, Forrest GN.
 Postgrad Med. 2009 Mar;121(2):107-13
 Abstract


Cryptococcosis
Yoshida K, Shoji H, Niki Y. et al
Nippon Rinsho. 2008 Dec;66(12):2350-5.
 Abstract
 
Cryptococcosis
Osuna A, Carragoso A, Lemos A, et al
Acta Med Port. 2008 May-Jun;21(3):307-13.
 Abstract
 
Profile of Central Nervous System Disease in HIV/AIDS Patients With Special Reference to
Cryptococcal Infections.
Wadhwa A, Kaur R, Bhalla P.
Neurologist. 2008 Jul;14(4):247-51
 Abstract
 
FULL TEXT ARTICLE
AIDS patient death caused by novel Cryptococcus neoformans × C. gattii hybrid.
Bovers M, Hagen F, Kuramae EE,  et al.
Emerg Infect Dis  . Vol 14, N07–July 2008
 Paper
 
FULL TEXT PDF ARTICLE
Comparison of Clinical Features and Survival between Cryptococcosis in Human
Immunodeficiency Virus (HIV)-Positive and HIV-Negative Patients.< font size="2" face="Arial">
Jongwutiwes U, Sungkanuparph S, Kiertiburanakul S. 
Jpn J Infect Dis. 2008 Mar;61(2):111-5.
 Paper
 
Cryptococcal inflammatory pseudotumors.
Sing Y, Ramdial PK.
Am J Surg Pathol. 2007 Oct;31(10):1521-7.
 Abstract
 
Cryptococcus neoformans, a fungus under stress.
Brown SM, Campbell LT, Lodge JK.
Curr Opin Microbiol. 2007 Aug;10(4):320-5.
Abstract
 
Non-neoformans cryptococcal infections: a systematic review.
Khawcharoenporn T, Apisarnthanarak A, Mundy LM.
Infection. 2007 Apr;35(2):51-8.
 Abstract

Sex-dependent resistance to the pathogenic fungus Cryptococcus neoformans.
van den Berg MC, Woerlee JZ, Ma H, May RC.  
Genetics. 2006 Apr 2;
 Abstract
 
Cryptococcosis in human immunodeficiency virus-negative patients.
Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, Sungkanuparph S.
Int J Infect Dis. 2006 Jan;10(1):72-8.
 Abstract
 
Cryptococcal disease and HIV infection.
Waters L, Nelson M.
Expert Opin Pharmacother. 2005 Dec;6(15):2633-44.
 Abstract
 
The prognosis of hearing impairment complicating HIV-negative cryptococcal meningitis.
Wang HC, Chang WN, Lui CC, Peng JP,
 Neurology. 2005 Jul 26;65(2):320-2.
 Abstract
 
Granuloma and cryptococcosis.
Shibuya K, Hirata A, Omuta J, 
J Infect Chemother. 2005 Jun;11(3):115-22.
 Abstract
 
Raised intracranial pressure complicating cryptococcal meningitis: immune reconstitution
inflammatory syndrome or recurrent cryptococcal disease?
York J, Bodi I, Reeves I, Riordan-Eva P, Easterbrook PJ.
J Infect. 2005 Jun 13;
Abstract
 
Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004).
Pfaller MA, Messer SA, Boyken L, et al   
J Clin Microbiol. 2005 May;43(5):2163-7.
 Abstract
 
Evidence for human immunodeficiency virus and Cryptococcus neoformans
interactions in the pro-inflammatory and anti-inflammatory responses in blood during
AIDS-associated cryptococcosis.
Lortholary O, Sitbon K, Dromer F, et al   
Clin Microbiol Infect. 2005 Apr;11(4):296-300
 Abstract
 
Cryptococcuria as a manifestation of disseminated cryptococcosis and isolated
urinary tract infection.
Kiertiburanakul S, Sungkanuparph S, Buabut B, Pracharktam R.
 Jpn J Infect Dis. 2004 Oct;57(5):203-5
 Abstract

Mediastinitis due to cryptococcal infection: a new clinical entity in the HAART era.
Trevenzoli M, Cattelan AM, Rea F, et al.
J Infect 2002 Oct;45(3):173-9
 Abstract

Cryptococcal infection in sarcoidosis.
Mehrany K, Kist JM, Gibson LE.
Int J Dermatol 2002 Nov;41(11):773-4
Abstract

  
Pathogenesis
 

       Journal Papers, Abstracts, and Commentaries

 
New Insights on the Pathogenesis of Invasive Cryptococcus neoformans Infection.
Eisenman HC, Casadevall A, McClelland EE.
Curr Infect Dis Rep. 2007 Nov;9(6):457-64
Abstract
 
Iron and fungal pathogenesis: a case study with Cryptococcus neoformans.
Jung WH, Kronstad JW.  
Cell Microbiol. 2007 Nov 27
Abstract
 
Phenotypic switching and its implications for the pathogenesis of Cryptococcus neoformans.
Jain N, Guerrero A, Fries BC.
FEMS Yeast Res. 2006 Jun;6(4):480-8.
Abstract
 
A clinical study of cryptococcal meningitis--sequential changes of cryptococcal
antigen titers
Kishi K, Homma S, Nakatani T, et al
Kansenshogaku Zasshi 2003 Mar;77(3):150-7
Abstract

Phenotypic switching in Cryptococcus neoformans.
Fries BC, Goldman DL, Casadevall A.
Microbes Infect 2002 Nov;4(13):1345-52
 Abstract

Pathogenesis of cryptococcal meningitis
Neuville S, Dromer F, Chretien F
Ann Med Interne (Paris) 2002 Sep;153(5):323-8
Abstract

Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia.
Chretien F, Lortholary O, Kansau I,
J Infect Dis 2002 Aug 15;186(4):522-30
Abstract

Immune mediators in cerebrospinal fluid during cryptococcosis are influenced |
by meningeal involvement and human immunodeficiency virus serostatus.
Lortholary O, Dromer F, Mathoulin-Pelissier S,et al.
J Infect Dis 2001 Jan 15;183(2):294-302
 Abstract

Cryptococcus neoformans isolated from patients with AIDS.
Fernandes Od, Costa TR, Costa MR,
Rev Soc Bras Med Trop 2000 Jan-Feb;33(1):75-8
 Abstract

  
Prevention
 

      Journal Papers, Abstracts, and Commentaries

 
Role of Complement in Protection Against Cryptococcus gattii Infection.
Mershon KL, Vasuthasawat A, Lawson GW, et al  
Infect Immun. 2008 Dec 29.
 Abstract
 
Prevention of cryptococcosis in HIV-infected patients with limited access to highly active
antiretroviral therapy: evidence for primary azole prophylaxis.
Caney P, Stephens D, Rimland D.
HIV Med. 2005 Jul;6(4):253-9
 Abstract
 
AIDS-associated Cryptococcus infection before and after the highly active antiretroviral therapy
era: emerging management problems.
Manfredi R, Calza L, Chiodo F.et al
Int J Antimicrob Agents. 2003 Oct;22(4):449-52.
Abstract

FULL-TEXT ARTICLE
 Guidelines for Preventing Opportunistic Infections Among HIV-Infected Persons -- 2002:
Recommendations of the U.S. Public Health Service and the Infectious
Diseases Society of America
 MMWR June 14, 2002 / Vol. 51 / No. RR--8   
Paper
   
  Cessation of secondary prophylaxis in patients with cryptococcosis.
Nwokolo NC, Fisher M, Gazzard BG, Nelson MR.  
AIDS 2001 Jul 27;15(11):1438-9
Abstract
 
     Conference Reports, Abstracts, and Posters
 
  Successful Primary Prevention of Cryptococcal Disease Using Fluconazole Prophylaxis in HIV-infected
Ugandan Adults
Rosalind Parkes-Ratanshi, A Kamali
(16 CROI)
Abstract
Diagnosis/Testing
 

     Journal Papers, Abstracts, and Commentaries

 
Detection of Antibody against Fungal Glucosylceramide in Immunocompromised Patients: A Potential New Diagnostic Approach for Cryptococcosis.
Qureshi A, Wray D, Rhome R,  et al
Mycopathologia. 2011 Oct 5
 Abstract

Rapid Identification of Cryptococcus neoformans var. grubii, C. neoformans var. neoformans,
and C. gattii Using Rapid Biochemical Tests, Differential Media, and DNA Sequencing.
McTaggart L, Richardson SE, Seah C,  et al J
Clin Microbiol. 2011 May 18
 Abstract

Assessing the Chronic Neuropsychologic Sequelae of Human Immunodeficiency
Virus-Negative Cryptococcal Meningitis by Using Diffusion Tensor Imaging.
Lu CH, Chen HL, Chang WN, et al
AJNR Am J Neuroradiol. 2011 May 19.
Abstract

The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in
HIV-infected patients with different ranges of CD4 cell counts.
Pongsai P, Atamasirikul K, Sungkanuparph S.
J Infect. 2010 Jun;60(6):474-7.
 Abstract

Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal
meningitis undergoing serial lumbar punctures.
 Bicanic T, Brouwer AE, Meintjes G, et al
AIDS. 2009 Mar 27;23(6):701-6.
 Abstract
 
Magnetic resonance imaging findings in AIDS patients with central nervous system cryptococcosis.
Corti M, Villafañe MF, Negroni R, et al. 
Rev Iberoam Micol. 2008 Dec;25(4):211-4
 Abstract
 
FULL TEXT PDF ARTICLE
Evaluation of conventional & serological methods for rapid diagnosis of cryptococcosis.
Saha DC, Xess I, Jain N.
Indian J Med Res. 2008 May;127(5):483-8.
Paper
 
False impressions from clear cerebrospinal fluid and a normal computed tomography scan:
the pressure is still on for a diagnosis.
Cartner M, Holley A, Allworth A. 
Emerg Med Australas. 2008 Jun;20(3):276-9.
 Abstract
 
Evaluation of conventional & serological methods for rapid diagnosis of cryptococcosis.
Saha DC, Xess I, Jain N, et al
Indian J Med Res. 2008 May;127(5):483-8
 Abstract
 
Histopathological techniques for diagnosing cryptococcosis due to capsule-deficient
Cryptococcus: case report.
Gazzoni AF, Pegas KL, Severo LC.
Rev Soc Bras Med Trop. 2008 Jan-Feb;41(1):76-8
 Abstract
 
Histopathological techniques for diagnosing cryptococcosis due to capsule-deficient
Cryptococcus: case report.
Gazzoni AF, Pegas KL, Severo LC.
Rev Soc Bras Med Trop. 2008 Jan-Feb;41(1):76-8.
Abstract
 
Cryptococcus neoformans Typing by PCR Fingerprinting Using (GACA)4 Primers Based on
C. neoformans Genome Project Data.
Cogliati M, Esposto MC, Liberi G, et al
J Clin Microbiol. 2007 Oct;45(10):3427-30
 Abstract
 
FUL -TEXT ARTICLE
Cryptococcal meningoencephalitis diagnosed by blood culture.
Sivasangeetha K, Harish BN, Sujatha S, et al
Indian J Med Microbiol. 2007 Jul;25(3):282-4.
Paper
 
Disseminated Cryptococcosis: Detection by F-18 FDG PET.
Seshadri N, Kaur B, Balan K.  
Clin Nucl Med. 2007 Jun;32(6):476-478.
 Abstract
 
Results obtained with various antifungal susceptibility testing methods do not predict
early clinical outcome in patients with cryptococcosis
Dannaoui E, Abdul M, Arpin M, et al   
Antimicrob Agents Chemother. 2006 Jul;50(7):2464-70.
Abstract
 
Simultaneous detection and identification of Candida, Aspergillus, and Cryptococcus species
by reverse line blot hybridization.
Playford EG, Kong F, Sun Y, Wang H, et al  
J Clin Microbiol. 2006 Mar;44(3):876-80.
Abstract
 
Utility of testing bronchoalveolar lavage fluid for cryptococcal ribosomal DNA.
Takahashi T, Goto M, Kanda T, Iwamoto A.
J Int Med Res. 2003 Jul-Aug;31(4):324-9.
Abstract

Detection of single cells of Cryptococcus neoformans in clinical samples by
solid-phase cytometry.
Bauters TG, Swinne D, Stove V, Nelis HJ.
J Clin Microbiol 2003 Apr;41(4):1736-7
Abstract
   
  Detection of Cryptococcus neoformans DNA in tissue samples bynested and
real-time PCR assays.
Bialek R, Weiss M, Bekure-Nemariam K, Najvar LK, et al.
Clin Diagn Lab Immunol 2002Mar;9(2):461-9
Abstract
   
  MRI finding of CNS cryptococcosis in an HIV-positive patient.
Mandokoro H, Tokuoka K, Ohnuki Y, et al. 
Rinsho Shinkeigaku 2001 Feb-Mar;41(2-3):154-6
 Abstract

     Conference Reports, Abstracts, and Posters

  Value of Systematic Screening of Cryptococcal Antigenemia for Early Diagnosis of Cryptococcosis
in HIV-Infected Patients in Cambodia
R. MICOL, O. LORTHOLARY, B. SAR,  et al
(45 ICAAC)
 Abstract
Clinical Management
 

     Journal Papers, Abstracts, and Commentaries

 
Clinical Practice Guidelines for the Management of Cryptococcal Disease:
2010 Update by the Infectious Diseases Society of America.
Perfect JR, Dismukes WE, Dromer F, et al
 Clin Infect Dis. 2010 Jan 4.
 Abstract

Treatment of cryptococcosis in the setting of HIV coinfection.
Khawcharoenporn T, Apisarnthanarak A, Mundy LM. 
Expert Rev Anti Infect Ther. 2007 Dec;5(6):1019-30.
 Abstract
 
FULL-TEXT ARTICLE
 Determinants of Disease Presentation and Outcome during Cryptococcosis:
The CryptoA/D Study.
Dromer F, Mathoulin-Pelissier S, Launay O, et al
 PLoS Med. 2007 Feb 6;4(2):e21
 Paper
 
Surgical treatment of primary pulmonary cryptococcosis.
Wang T, Sun YE, Yu CH, Yang B, Sun K, Zhou ZH.
Zhonghua Wai Ke Za Zhi. 2005 Nov;43(22):1447-9.
 Abstract

Immune reconstitution cryptococcosis after initiation of successful highly active
antiretroviral therapy.
Jenny-Avital ER, Abadi M.
Clin Infect Dis 2002 Dec 15;35(12):E128-33
 Abstract

Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal
infections with liposomal amphotericin B.
Chen SC. 
J Antimicrob Chemother 2002 Jan;49 Suppl A:57-61
 Abstract

Successful discontinuation of fluconazole as secondary prophylaxis for
cryptococcosis in AIDS patients responding to highly active antiretroviral therapy.
Sheng WH, Hung CC, Chen MY, et al.
Int J STD AIDS 2002 Oct;13(10):702-5

Cryptococcosis in human immunodeficiency virus-negative patients in the era of
effective azole therapy.
Pappas PG, Perfect JR, Cloud GA , et al.
Clin Infect Dis 2001 Sep 1;33(5):690-9
 Abstract

  
Transplant Studiers
       

     Journal Papers, Abstracts, and Commentaries

 
Cryptococcosis in organ transplantation.
Islam S, Das A, Islam N. 
Mymensingh Med J. 2010 Jan;19(1):142-3.
 Abstract

Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal
neuroimaging findings.
Singh N, Lortholary O, Dromer F, et al
Transplantation. 2008 Sep 15;86(5):647-51
 Abstract
 
Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum
cryptococcal antigen.
Singh N, Alexander BD, Lortholary O, et al
Clin Infect Dis. 2008 Jan 15;46(2)
 Abstract
 
Cellulitis revealing a cryptococcosis-related immune reconstitution inflammatory syndrome in a
renal allograft recipient.
Lanternier F, Chandesris MO, Poirée S, et al  
Am J Transplant. 2007 Dec;7(12):2826-8.
Abstract

Calcineurin-inhibitor agents interact synergistically with antifungal agents in vitro against
Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant
recipients with cryptococcosis.
Kontoyiannis DP, Lewis RE, Lortholary O, et al 
Antimicrob Agents Chemother. 2007 Dec 10
 Abstract

Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients.
Saha DC, Goldman DL, Shao X, et al   
Clin Vaccine Immunol. 2007 Dec;14(12):1550-4.
 Abstract

Systemic and cerebrospinal fluid T-helper cytokine responses in organ transplant recipients
with Cryptococcus neoformans infection.
Singh N, Husain S, Limaye AP, et al 
Transpl Immunol. 2006 Aug;16(2):69-72.
 Abstract
 
Cryptococcosis in organ transplant recipients: an overview.
Vilchez RA, Fung J, Kusne S.et al.
Am J Transplant 2002 Aug;2(7):575-80
Abstract

Guidelines and Recommendations
United States      

United States

       Journal Papers, Abstracts, and Commentaries

  FULL-TEXT ARTICLE
 Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents:
Recommendations from CDC, the National Institutes of Health, and the HIV
Medicine Association/Infectious Diseases Society of America
MMWR Dec 17, 2004 / Vol. 53 / No. RR--1
Paper
 

OI Main Page Disease Main Page Main New/Newsworthy  Home Page 

Cryptococcosis Main Page